Phase I/II Studie zur Dokumentation der immunmodulierenden, zytotoxischen und der möglichen Anti-HIV-Wirkungen von Iscador (IND # 32,829)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details